SCHEMBL6380600

SCHEMBL6380600

CC1(Sc2ccc(OCc3ccc(F)cc3)cc2)C(=O)NC(=O)NC1=O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 2/20 0.49
▸ MMP2 P08253 1/20 0.49
▸ CTSL P07711 1/20 0.48
▸ CTSB P07858 1/20 0.48
▸ MAOB P27338 10/20 0.47
▸ APP P05067 1/20 0.46
▸ PTPN1 P18031 1/20 0.45
▸ NR4A2 P43354 1/20 0.45
▸ MMP14 P50281 1/20 0.45
▸ MAOA P21397 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA7 P43166 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ PARP10 Q53GL7 1/20 0.44
▸ OPRM1 P35372 1/20 0.42
▸ OPRD1 P41143 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6378851 0.82 MMP13 (0.47) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6383331 0.80 MMP13 (0.54) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6378753 0.77 MMP13 (0.49) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6375133 0.76 CA12 (0.56) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6383052 0.76 MMP13 (0.48) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6378913 0.75 MMP13 (0.56) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6379245 0.74 CTSL (0.48) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6378849 0.74 MMP13 (0.47) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6379189 0.73 CTSL (0.49) MMP13MMP2CTSLCTSBMAOB
SCHEMBL6379044 0.72 MMP13 (0.50) MMP13MMP2CTSLCTSBMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202974-B1 PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS PFIZER PROD INC (US) 2005-11-09 — — EP disclosed
US-6579982-B1 Treating inflammation, cancer PFIZER INC. 2003-06-17 — — US disclosed
EP-1202974-A1 PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS Pfizer Products Inc. (US) 2002-05-08 — — EP disclosed
WO-2001012611-A1 PYRIMIDINE-2,4,6-TRIONE METALLOPROTEINASE INHIBITORS PFIZER PRODUCTS INC. (US) 2001-02-22 — — WO disclosed
Send feedback